Inhibition of HEV Replication by FDA-Approved RdRp Inhibitors

[Image: see text] Hepatitis E virus (HEV) is primarily a hepatotropic virus that is responsible for acute hepatitis E in the general population and for chronic hepatitis in immunocompromised individuals. In the absence of a globally accessible vaccine, pegylated interferon-α and ribavirin are the on...

Descripción completa

Detalles Bibliográficos
Autores principales: Hooda, Preeti, Al-Dosari, Mohammed, Sinha, Neha, Parvez, Mohammad K., Sehgal, Deepak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633873/
https://www.ncbi.nlm.nih.gov/pubmed/37969986
http://dx.doi.org/10.1021/acsomega.3c05637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633873/
https://www.ncbi.nlm.nih.gov/pubmed/37969986
http://dx.doi.org/10.1021/acsomega.3c05637

Ejemplares similares